about
PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models.The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesotheliomaEstablishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient.Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.Aurora kinase A gene copy number is associated with the malignant transformation of colorectal adenomas but not with the serrated neoplasia progression.Diagnostic revision of 206 adult gliomas (including 40 oligoastrocytomas) based on ATRX, IDH1/2 and 1p/19q status.The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models.Ex vivo allogeneic stimulation significantly improves expansion of cytokine-induced killer cells without increasing their alloreactivity across HLA barriersThe Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for TreatmentThe expression of LINE1-MET chimeric transcript identifies a subgroup of aggressive breast cancers
P50
Q33617922-073596DA-6F10-4F40-9334-B7CA8A2CB327Q35599789-613AFF59-46CB-472A-90C5-D9FFF928EC88Q36834539-CB67BD91-079A-453E-9420-2C5154B83F14Q39041744-D71E2A0E-0120-48EA-96BD-6072ECB2C43AQ41570412-B3EFFC01-E2E9-438B-95D0-E9D47499F4E2Q48450133-AE027E76-D48B-4AA2-A075-2FD55E0B704EQ53119067-0F4D6CDB-BA15-4635-8E15-F25253817518Q84794522-D7438402-36DB-457F-BD4B-CD0F0832DFBCQ89428605-FF75B684-B7E3-4A07-9E59-562DE916A0ABQ91135234-486313EE-508E-4A8A-9102-365E49C5E409
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Carmine Dell'aglio
@en
Carmine Dell'aglio
@nl
type
label
Carmine Dell'aglio
@en
Carmine Dell'aglio
@nl
prefLabel
Carmine Dell'aglio
@en
Carmine Dell'aglio
@nl
P31
P496
0000-0003-2089-1077